NADPH homeostasis in cancer: functions, mechanisms and therapeutic implications.

Ju HQ, Lin JF, Tian T, Xie D, Xu RH. · 2020

Read NADPH homeostasis in cancer: functions, mechanisms and therapeutic implications. by Ju HQ, Lin JF, Tian T, Xie D, Xu RH. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7542157.txt.

Introduction

Ju and co-authors review NADPH balance in cancer cells. NADPH supplies reducing power for building molecules. It also helps cells keep redox balance under stress.

Cancer cells rewire NADPH pathways as they adapt. That rewiring makes them rely on the network for defense. It also leaves them open to oxidative harm. The review covers how signals and enzymes control NADPH levels. It then covers treatments that target this system. Aiming at NADPH may help kill cancer cells. Readers get functions, controls and drug ideas in one place. The work links basic metabolism to cancer therapy choices.

Catalog record

CREATORJu HQ, Lin JF, Tian T, Xie D, Xu RH.
YEAR2020
COLLECTIONPAPERS
FORMATTXT
FILE SIZE80 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC7542157

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

NADPH homeostasis in cancer: functions, mechanisms and therapeutic implications By Huai-Qiang Ju, Jin-Fei Lin, Tian Tian, Dan Xie, Rui-Hua Xu Published in: Signal Transduction and Targeted Therapy DOI: 10.1038/s41392-020-00326-0 ABSTRACT Nicotinamide adenine dinucleotide phosphate (NADPH) is an essential electron donor in all organisms, and provides the reducing power for anabolic reactions and redox balance. NADPH homeostasis is regulated by varied signaling pathways and several metabolic enzymes that undergo adaptive alteration in cancer cells. The metabolic reprogramming of NADPH renders cancer cells both highly dependent on this metabolic network for antioxidant capacity and more susceptible to oxidative stress. Modulating the unique NADPH homeostasis of cancer cells might be an effective strategy to eliminate these cells. In this review, we summarize the current existing literatures on NADPH homeostasis, including its biological functions, regulatory mechanisms and the corresponding therapeutic interventions in human cancers, providing insights into therapeutic implications of targeting NADPH metabolism and the associated mechanism for cancer therapy. BACKGROUND In cancer cells, the appropriate levels of intracellular reactive oxygen species (ROS) are essential for signal transduction and cellular processes.1,2 However, the overproduction of ROS can induce cytotoxicity and lead to DNA damage and cell apoptosis.3 To prevent excessive oxidative stress and maintain favorable redox homeostasis, tumor cells have evolved a complex antioxidant defense system that strategically adjusts multiple antioxidant enzymes such as catalase, glutathione reductase, and antioxidant molecules. The latter are dependent on the generation of nicotinamide adenine dinucleotide phosphate (NADPH), which is used to maintain reduced glutathione (GSH) and thioredoxin (TRX).4–6 NADPH is also well known as an essential electron donor and an indispensable cofactor that is used for transferring and reserving reduction potential for numerous anabolic reactions.7 NADP(H) is predominantly bound to intracellular proteins with different affinities.8 The intracellular content of NADP(H) differs markedly among tissues and cell types. For instance, the total NADP(H) is about 420 nmol/g wet weight in rat liver and 59% of total NADP(H) is found in mitochondria, and 30 nmol/g wet weight in skeletal muscle,5,8 and the NADPH concentration in the cytosol is 3.1 ± 0.3 and 37 ± 2 µM in the mitochondrial matrix in HeLa cells.9 In addition, the redox potentials of the mitochondrial and cytosolic NADP(H) systems are the same around—400 mV in the liver.8 A growing body of evidence has shown that regeneration and maintenance of the cellular NADP(H) content is strongly implicated in a variety of pathological conditions, such as diabetes, cardiovascular disease, neurodegenerative diseases, aging,4,5 especially in tumorigenesis and cancer progression.10 Compared with non-tumor cells, tumor cells usually maintain high levels of NADPH, not only to power redox defense but also to use for biosynthetic reactions to sustain their rapid growth.5,11 This realization has prompted molecular studies of NADPH metabolism and its exploitation for the development of anticancer agents. Recent advances have revealed that therapeutic modulation based on NADPH metabolism has been widely viewed as a novel and effective anticancer strategy. In this review, we summarize the current existing literatures on NADPH metabolism, including its biological functions, regulatory mechanisms, and the corresponding therapeutic interventions directly or indirectly targeting NADPH metabolism in cancer. NADPH-DEPENDENT BIOLOGICAL FUNCTIONS IN CANCER Both NAD(H) and NADP(H) are cofactors that are used for transferring and reserving reduction potential.7,9 Although the structures are closely related, NAD(H) and NADP(H) are recognized by unique compartmentalized enzymes and exert different functions. NAD(H) is mainly involved in catabolic reactions,5,12,13 whereas NADP(H) is primarily involved in cellular antioxidative effects and anabolic reactions as shown in Fig. 1.Fig. 1NADPH-dependent biological functions in cancer. There are three principal ways in which NADPH is used. First, NADPH is an essential cofactor of glutathione reductase (GR) and TRXR in GSH and TRX-peroxiredoxin (PRX) system, respectively, and reactivates catalase (CAT) to deactivate ROS for antioxidation; Second, NADPH is a crucial electron source for DHFR, Fe/S, POR, FANS, HMGCR, DPYD contributing to several reductive synthesis reactions, such as FAS, non-essential amino acids, nucleotides, and steroids synthesis; Third, NADPH is a substrate for NOXs to generate ROS Antioxidative effects In cancer cells, overcoming oxidative stress is a critical step for tumor progression. NADPH plays a key role in cellular antioxidation systems by providing reducing equivalents to generate reduced forms of antioxidant molecules, which are highly corrected with cancer cell biological behaviors.14 On the one hand, GSH reductase converts GSSG to GSH using NADPH as an important cofactor, then GSH acts as a cosubstrate for GSH peroxidase (GPX) that reduces hydrogen peroxide (H2O2) and other peroxides to H2O or alcohol to deactivate ROS.15,16 On the other hand, TRX reductase (TRXR) utilizes NADPH as an electron donor to maintain the reduced form of TRX, which contributes to scavenge H2O2 and reduce ribonucleotide reductase (RNR) for DNA synthesis.17,18 In addition, in some cell types, NADPH binds to the important H2O2-disposing enzyme: catalase, and reactivates it when it has been inactivated by H2O2.19 Reductive synthesis NADPH is also a crucial electron source for several reductive synthesis reactions, including fatty acids, amino acids, nucleotides, and steroids synthesis to sustain rapid tumor cell growth.20 Primarily, NADPH provides reducing equivalents for fatty acid synthase (FASN), the main rate-limiting enzyme, to synthesize fatty acids with acetyl-CoA serving as a primer and malonyl-CoA as a two-carbon donor,21,22 and provides the needed electrons for iron–sulfur (Fe/S) protein assembly that participate in non-essential amino acid biosynthesis and lipoic acid synthesis, tRNA modification, DNA replication and repair, and telomere maintenance.23 NADPH is also needed for dihydrofolate reductase (DHFR) enzyme to catalyze the reduction of dihydrofolate to tetrahydrofolate (THF) in folate metabolism, which is required for de novo biosynthesis of thymidylate, purines, methionine, and some amino acids.24 Besides, NADPH acts as the reducing reagent for 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR), the rate-limiting enzyme of the mevalonate pathway, which leads to the synthesis of cholesterol and nonsterol isoprenoids.25 NADPH also acts as a cosubstrate for dihydropyrimidine dehydrogenase (DPYD), which catalyzes the reduction of uracil and thymine to 5,6-dihydrouracil and 5,6-dihydrothymine, respectively.26 In addition, the activity of the cytochrome P450 reductase (POR) also requires NADPH, which has a major role in the metabolism of drugs, xenobiotics, and steroid hormones.27 Free radical generation In addition, NADPH is also responsible for the generation of free radicals by NADPH oxidases (NOX) as a substrate. NOXs (NOX1–5 and dual oxidases (DUOX) 1 and 2) catalyze the superoxide anions or H2O2 from NADPH and oxygen.28–30 NOX-mediated ROS broadly and specifically regulate various redox-sensitive signaling pathways involved in cancer progression via stimulating oncogenes, such as Src and Ras, and inactivating tumor suppressor proteins, such as TP53 and PTEN.31 MOLECULAR MECHANISMS OF NADPH HOMEOSTASIS IN CANCER Understanding NADPH production and consumption routes is essential to a global understanding of cancer metabolism. As shown in Fig. 2, the NADPH homeostasis is mainly regulated by several metabolic pathways and enzymes including NAD kinase (NADK), the pentose phosphate pathway (PPP), the folate-mediated one-carbon metabolism, malic enzymes (ME), the nicotinamide nucleotide transhydrogenase (NNT), cytosolic or mitochondrial NADP-dependent isocitrate dehydrogenase (IDH1 and IDH2), the glutamine metabolism, and the fatty acid oxidation (FAO). However, for the general NADPH generation in cells, the relative contribution of these pathways and enzymes to NADPH production remains elusive. Recent study show that cellular NADPH could be largely generated by PPP, the folate-mediated one-carbon metabolism and ME in cancer and proliferation cells.32,33

Read the complete text